Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PEG-INTERFERON ALFA 2A for Chronic hepatitis c: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 127 adverse event reports in the FDA FAERS database where PEG-INTERFERON ALFA 2A was used for Chronic hepatitis c.

Most Reported Side Effects for PEG-INTERFERON ALFA 2A

Side Effect Reports % Deaths Hosp.
Anaemia 43 16.4% 5 22
Pancytopenia 25 9.5% 2 10
Leukopenia 21 8.0% 3 10
Hepatitis c 19 7.3% 5 0
Thrombocytopenia 17 6.5% 3 7
Neutropenia 15 5.7% 2 3
Rash 12 4.6% 3 5
Fatigue 10 3.8% 3 4
Renal failure acute 10 3.8% 3 6
Pneumonia 9 3.4% 1 7
Renal failure 9 3.4% 1 8
Ascites 8 3.1% 1 6
Drug resistance 8 3.1% 0 0
Haemoglobin decreased 8 3.1% 0 3
Sepsis 8 3.1% 6 3

Other Indications for PEG-INTERFERON ALFA 2A

Hepatitis c (110) Hepatic cirrhosis (6) Chronic hepatitis b (5)

Other Drugs Used for Chronic hepatitis c

RIBAVIRIN (15,707) PEGINTERFERON ALFA-2A (7,898) LEDIPASVIR\SOFOSBUVIR (6,621) SOFOSBUVIR\VELPATASVIR (6,405) SOFOSBUVIR (6,008) TELAPREVIR (3,103) GLECAPREVIR\PIBRENTASVIR (3,072) SIMEPREVIR (2,735) DACLATASVIR (2,063) PEGINTERFERON ALFA-2B (1,927)

Related Pages

PEG-INTERFERON ALFA 2A Full Profile All Chronic hepatitis c Drugs PEG-INTERFERON ALFA 2A Demographics PEG-INTERFERON ALFA 2A Timeline